Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review.

Abstract	TRIAL REGISTRATION: Registered with PROSPERO ( CRD42021267844 ) dated 14.07.2021.
Authors	Amit Kumar Rai, Azeem Ahmad, Pallavi Mundada, Krishna Kumar V, Babita Yadav, Shruti Khanduri, Bhogavalli Chandrasekhararao, Narayanam Srikanth
Journal	Systematic reviews (Syst Rev) Vol. 11 Issue 1 Pg. 103 (05 24 2022) ISSN: 2046-4053 [Electronic] England
PMID	35610729 (Publication Type: Letter)
Copyright	© 2022. The Author(s).
Chemical References	Ayush 64 Plant Extracts
Topics	COVID-19 Humans Plant Extracts SARS-CoV-2 Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!